Koers Orchid Ventures, Inc. Canadian Securities Exchange
Aandelen
ORCD
CA68573L2066
Farmaceutische producten
Omzet 2020 | 1,45 1,98 1,35 | Omzet 2021 | 3,72 5,09 3,47 | Marktkapitalisatie | 10,45 mln. 14,3 mln. 9,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -6 mln. -8,21 mln. -5,6 mln. | Nettowinst (verlies) 2021 | -3 mln. -4,1 mln. -2,8 mln. | EV/omzet 2020 | 2.373.049 x |
Nettoschuld 2020 | 363K 497K 339K | Nettoliquiditeiten 2021 | 1 mln. 1,37 mln. 936K | EV/omzet 2021 | 2.540.035 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-2,02
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 79,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 819 mld. | |
-6,75% | 351 mld. | |
+13,56% | 329 mld. | |
+10,68% | 298 mld. | |
+16,57% | 242 mld. | |
+2,04% | 225 mld. | |
+13,31% | 217 mld. | |
+8,48% | 168 mld. | |
-2,81% | 158 mld. |